Screener
Upstream Bio, Inc. UPB Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Collaboration revenue | $773 | $937 | $1,807 | $1,503 |
| Operating expenses: | ||||
| Research and development | 36,089 | 37,865 | 72,654 | 63,662 |
| General and administrative | 7,052 | 7,419 | 15,136 | 14,201 |
| Total operating expenses | 43,141 | 45,284 | 87,790 | 77,863 |
| Loss from operations | (42,368) | (44,347) | (85,983) | (76,360) |
| Other income (expense): | ||||
| Interest income | 2,659 | 4,431 | 5,713 | 9,174 |
Item 1. Financial Statements.
FAQ
- What is Upstream Bio, Inc.'s total revenue?
- Upstream Bio, Inc. (UPB) reported total revenue of $773K in Q2 2026.
- How has Upstream Bio, Inc.'s total revenue changed year-over-year?
- Upstream Bio, Inc.'s total revenue decreased by 17.5% year-over-year, from $937K to $773K.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Upstream Bio, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude